Pure Global

LIAISON® PSA - India CDSCO Medical Device Registration

LIAISON® PSA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000089_fd678b26f00c43507dac1181dfa068d4_f03e00149ad60b7d1bfb8661e01686b6. This device is marketed under the brand name LIAISON® Tg II Gen Confirmatory. The license holder is Diasorin Healthcare India Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
LIAISON® PSA
UID: IMP/IVD/2019/000089_fd678b26f00c43507dac1181dfa068d4_f03e00149ad60b7d1bfb8661e01686b6

Brand Name

LIAISON® Tg II Gen Confirmatory

Device Class

Class C

Approving Authority

CDSCO

Product Information

In vitro assay for the quantitative determination of human prostate-specific antigen (LIAISON® Tg II Gen Confirmatory) in human serum and plasma (LIAISON® Tg II Gen Confirmatory) during the follow-up of patients with carcinoma of the prostate. The test has to be performed on the LIAISON® Analyzer family

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing